Metraipolis › archive › dc_ab86231c3ca5
Industry-defined opportunities for advancing big data capabilities in biopharmaceutical manufacturing — Europe PMC PMID:42761237
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42761237
- DOI
- 10.3389/fbioe.2026.1886721
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T17:34:13.492Z
- SHA-256 of the archived text
d82ea20fd3c7b236109517c04a99e0990f8c5d3ea0db11744f35706be2e71e43- Stable URL of this page
https://metraipolis.com/documento/dc_ab86231c3ca5
How to cite
Industry-defined opportunities for advancing big data capabilities in biopharmaceutical manufacturing — Europe PMC PMID:42761237 — Europe PMC (en), https://europepmc.org/article/MED/42761237 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ab86231c3ca5 (Metraipolis archive dc_ab86231c3ca5, sha256 d82ea20fd3c7b236109517c04a99e0990f8c5d3ea0db11744f35706be2e71e43)
BibTeX
@misc{dcab86231c3ca5,
title = {Industry-defined opportunities for advancing big data capabilities in biopharmaceutical manufacturing — Europe PMC PMID:42761237},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42761237},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ab86231c3ca5; sha256 d82ea20fd3c7b236109517c04a99e0990f8c5d3ea0db11744f35706be2e71e43},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42761237. Agents can read the archived copy with the MCP tool read_document.